Patrick Redmond, MD
Ophthalmology · Alexandria, LANPI 1568780195
Payments from drug & device makers
Across 287 payments — averaging $43.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$4K
- Glaukos Corporation$3K
- AbbVie$1K
- Sight Sciences, Inc.$745
- Ivantis, Inc$680
- NEW World Medical,inc.$668
- plus $2K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 93 | $4,005 |
| Glaukos Corporation | 27 | $3,040 |
| AbbVie(2 entities) | 34 | $1,084 |
| Sight Sciences, Inc. | 18 | $745 |
| Ivantis, Inc | 12 | $680 |
| NEW World Medical,inc. | 13 | $668 |
| Johnson & Johnson Surgical Vision, Inc. | 17 | $663 |
| Rxsight Inc | 5 | $248 |
| Genentech USA, Inc. | 3 | $227 |
| Ocular Therapeutix, Inc. | 12 | $175 |
| Sun Pharmaceutical Industries Inc. | 7 | $148 |
| Biotissue Holdings Inc. | 4 | $141 |
| Aerie Pharmaceuticals, Inc. | 6 | $99 |
| Mallinckrodt Hospital Products Inc. | 4 | $91 |
| Biogen | 4 | $78 |
| Bausch & Lomb Americas Inc. | 4 | $75 |
| Amgen(2 entities) | 4 | $70 |
| Apellis Pharmaceuticals, Inc. | 3 | $66 |
| Oyster Point Pharma, Inc. | 3 | $62 |
| Rayner Intraocular Lenses Limited | 3 | $52 |
| Tarsus Pharmaceuticals, Inc. | 2 | $36 |
| Omeros Corporation | 2 | $28 |
| Novartis | 2 | $25 |
| Dompe US, Inc. | 1 | $23 |
| Nova Eye, Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $15 |
| Harrow Eye, LLC | 1 | $15 |
| Eyevance Pharmaceuticals LLC | 1 | $12 |
How this compares
$12,593 in reported general payments places this provider in the 90th percentile of 286 ophthalmology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Alexandria
- Eric ReishAlexandria$158K
- Michael RedmondAlexandria$24K
- Thomas NortonAlexandria$8K
- Blake WilliamsonBaton Rouge$482K
- William ReadMonroe$303K
- Delmar CaldwellNew Orleans$282K
- Ruben GrigorianWest Monroe$192K
- Wyche ColemanShreveport$130K
- Ze ZhangNew Orleans$103K
- Rebecca MetzingerNew Orleans$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.